Diagnosis of cardiac involvement in systemic amyloidosis by state-of-the-art echocardiography: where are we now?

References

• Hunstein W. Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option? Blood. 2007;110:2216.
   PubMed Web of Science ®Google Scholar
• Mereles D, Wanker EE, Katus HA. Therapy effects of green tea in a patient with systemic light-chain amyloidosis. Clin Res Cardiol. 2008;97:341–344.
   PubMed Web of Science ®Google Scholar
• Mereles D, Buss SJ, Hardt SE, et al. Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis. Clin Res Cardiol. 2010;99:483–490.
   PubMed Web of Science ®Google Scholar
• Mereles D, Hunstein W. Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises? Int J Mol Sci. 2011;12:5592–5603.
   PubMed Web of Science ®Google Scholar
• Kristen AV, Lehrke S, Buss S, et al. Green tea halts progression of cardiac transthyretin amyloidosis: an observational report. Clin Res Cardiol. 2012;101:805–813.
   PubMed Web of Science ®Google Scholar
• Siepen FA, Bauer R, Aurich M, et al. Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study. Drug Des Devel Ther. 2015 Dec;4(9):6319–6325.
   Web of Science ®Google Scholar
• Kyle RA, Spittell PC, Gertz MA, et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med. 1996;101:395–400.
   PubMed Web of Science ®Google Scholar
• Dubrey SW, Cha K, Skinner M, et al. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart. 1997;78:74–82.
   PubMed Web of Science ®Google Scholar
• Cappelli F, Baldasseroni S, Bergesio F, et al. Echocardiographic and biohumoral characteristics in patients with AL and ATTR amyloidosis at diagnosis. Clin Cardiol. 2015;38:69–75.
   PubMed Web of Science ®Google Scholar
• Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol. 2005;79:319–328.
   PubMed Web of Science ®Google Scholar
• Child JS, Levisman JA, Abbasi AS, et al. Echocardiographic manifestations of infiltrative cardiomyopathy. A report of seven cases due to amyloid. Chest. 1976;70:726–731.
   PubMed Web of Science ®Google Scholar
• Siqueira-Filho AG, Cunha CL, Tajik AJ, et al. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation. 1981;63:188–196.
   PubMed Web of Science ®Google Scholar
• Carroll JD, Gaasch WH, McAdam KP. Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. Am J Cardiol. 1982;49:9–13.
   PubMed Web of Science ®Google Scholar
• Eriksson P, Backman C, Bjerle P, et al. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy. Br Heart J. 1984;52:321–326.
   PubMedGoogle Scholar
• Nicolosi GL, Pavan D, Lestuzzi C, et al. Prospective identification of patients with amyloid heart disease by two-dimensional echocardiography. Circulation. 1984;70:432–437.
   PubMed Web of Science ®Google Scholar
• Hongo M, Ikeda S. Echocardiographic assessment of the evolution of amyloid heart disease: a study with familial amyloid polyneuropathy. Circulation. 1986;73:249–256.
   PubMed Web of Science ®Google Scholar
• Falk RH, Plehn JF, Deering T, et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol. 1987;59:418–422.
   PubMed Web of Science ®Google Scholar
• Klein AL, Hatle LK, Burstow DJ, et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1989;13:1017–1026.
   PubMed Web of Science ®Google Scholar
• Kinoshita O, Hongo M, Yamada H, et al. Impaired left ventricular diastolic filling in patients with familial amyloid polyneuropathy: a pulsed Doppler echocardiographic study. Br Heart J. 1989;61:198–203.
   PubMedGoogle Scholar
• Abdalla I, Murray RD, Lee JC, et al. Duration of pulmonary venous atrial reversal flow velocity and mitral inflow a wave: new measure of severity of cardiac amyloidosis. J Am Soc Echocardiogr. 1998;11:1125–1133.
   PubMed Web of Science ®Google Scholar
• Koyama J, Ray-Sequin PA, Davidoff R, et al. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol. 2002;89:1067–1071.
   PubMed Web of Science ®Google Scholar
• Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003;107:2446–2452.
   PubMed Web of Science ®Google Scholar
• Sun JP, Stewart WJ, Yang XS, et al. Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. Am J Cardiol. 2009;103:411–415.
   PubMed Web of Science ®Google Scholar
• Porciani MC, Cappelli F, Perfetto F, et al. Rotational mechanics of the left ventricle in AL amyloidosis. Echocardiography. 2010;27:1061–1068.
   PubMed Web of Science ®Google Scholar
• Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98:1442–1448.
   PubMed Web of Science ®Google Scholar
• Baccouche H, Maunz M, Beck T, et al. Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography. Echocardiography. 2012;29:668–677.
   PubMed Web of Science ®Google Scholar
• Liu D, Hu K, Niemann M, et al. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013;6:1066–1072.
   PubMed Web of Science ®Google Scholar
• Nemes A, Földeák D, Domsik P, et al. Different patterns of left ventricular rotational mechanics in cardiac amyloidosis-results from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study. Quant Imaging Med Surg. 2015;5:853–857.
   PubMedGoogle Scholar
• Lee GY, Kim HK, Choi JO, et al. Visual assessment of relative apical sparing pattern is more useful than quantitative assessment for diagnosing cardiac amyloidosis in borderline or mildly increased left ventricular wall thickness. Circ J. 2015;79:1575–1584.
   PubMed Web of Science ®Google Scholar
• Caidahl K, Kazzam E, Lidberg J, et al. New concept in echocardiography: harmonic imaging of tissue without use of contrast agent. Lancet. 1998;352:1264–1270.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.
   PubMed Web of Science ®Google Scholar
• Klein AL, Hatle LK, Burstow DJ, et al. Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1990;15:99–108.
   PubMed Web of Science ®Google Scholar
• Klein AL, Hatle LK, Taliercio CP, et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1990;16:1135–1341.
   PubMed Web of Science ®Google Scholar
• Plehn JF, Southworth J, Cornwell GG 3rd. Brief report: atrial systolic failure in primary amyloidosis. N Engl J Med. 1992;327:1570–1573.
   PubMed Web of Science ®Google Scholar
• Moyssakis I, Triposkiadis F, Pantazopoulos NJ, et al. Left atrial systolic function in primary and familial amyloidosis: assessment from left atrial volume change. Clin Cardiol. 2004;27:528–532.
   PubMed Web of Science ®Google Scholar
• Modesto KM, Dispenzieri A, Cauduro SA, et al. Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J. 2005;26:173–179.
   PubMed Web of Science ®Google Scholar
• Koyama J, Davidoff R, Falk RH. Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr. 2004;17:36–44.
   PubMed Web of Science ®Google Scholar
• Liu D, Niemann M, Hu K, et al. Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis. Am J Cardiol. 2011;108:591–598.
   PubMed Web of Science ®Google Scholar
• Urbano-Moral JA, Gangadharamurthy D, Comenzo RL, et al. Three-dimensional speckle tracking echocardiography in light chain cardiac amyloidosis: examination of left and right ventricular myocardial mechanics parameters. Rev Esp Cardiol. 2015;68:657–664.
   PubMed Web of Science ®Google Scholar
• Dalen H, Thorstensen A, Aase SA, et al. Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the HUNT study in Norway. Eur J Echocardiogr. 2010;11:176–183.
   PubMed Web of Science ®Google Scholar
• Cueto-Garcia L, Reeder GS, Kyle RA, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol. 1985;6:737–743.
   PubMed Web of Science ®Google Scholar
• Klein AL, Hatle LK, Taliercio CP, et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation. 1991;83:808–816.
   PubMed Web of Science ®Google Scholar
• Patel AR, Dubrey SW, Mendes LA, et al. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol. 1997;80:486–492.
   PubMed Web of Science ®Google Scholar
• Koyama J, Ray-Sequin PA, Falk RH. Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation. 2002;106:556–561.
   PubMed Web of Science ®Google Scholar
• Koyama J, Falk RH. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging. 2010;3:333–342.
   PubMed Web of Science ®Google Scholar
• Buss SJ, Emami M, Mereles D, et al. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol. 2012;60:1067–1076.
   PubMed Web of Science ®Google Scholar
• Liu D, Hu K, Störk S, et al. Predictive value of assessing diastolic strain rate on survival in cardiac amyloidosis patients with preserved ejection fraction. PLoS One. 2014;9:e115910.
   Google Scholar
• Kristen AV, Scherer K, Buss S, et al. Noninvasive risk stratification of patients with transthyretin amyloidosis. JACC Cardiovasc Imaging. 2014;7:502–510.
   PubMed Web of Science ®Google Scholar
• Nakahashi T, Arita T, Yamaji K, et al. Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy. Int J Cardiol. 2014;176:753–759.
   PubMed Web of Science ®Google Scholar
• Riffel JH, Mereles D, Emami M, et al. Prognostic significance of semiautomatic quantification of left ventricular long axis shortening in systemic light-chain amyloidosis. Amyloid. 2015;22:45–53.
   PubMed Web of Science ®Google Scholar
• Hu K, Liu D, Nordbeck P, et al. Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis. Int J Cardiovasc Imaging. 2015;31:1401–1412.
   PubMed Web of Science ®Google Scholar
• Yuda S, Hayashi T, Yasui K, et al. Pericardial effusion and multiple organ involvement are independent predictors of mortality in patients with systemic light chain amyloidosis. Intern Med. 2015;54:1833–1840.
   PubMed Web of Science ®Google Scholar
• Gerges M, Gerges C, Pistritto AM, et al. Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival. Am J Respir Crit Care Med. 2015;192:1234–1246.
   PubMed Web of Science ®Google Scholar
• Frea S, Pidello S, Bovolo V, et al. Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure. Eur J Heart Fail. 2016. doi:10.1002/ejhf.504.
   PubMed Web of Science ®Google Scholar
• Grapsa J, Pereira Nunes MC, Tan TC, et al. Echocardiographic and hemodynamic predictors of survival in precapillary pulmonary hypertension: seven-year follow-up. Circ Cardiovasc Imaging. 2015;8:e002107.
   Web of Science ®Google Scholar
• Ghio S, Perlini S, Palladini G, et al. Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis. Eur J Heart Fail. 2007;9:808–813.
   PubMed Web of Science ®Google Scholar
• Bellavia D, Pellikka PA, Dispenzieri A, et al. Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study. Eur Heart J Cardiovasc Imaging. 2012;13:680–689.
   PubMed Web of Science ®Google Scholar
• Cappelli F, Porciani MC, Bergesio F, et al. Right ventricular function in AL amyloidosis: characteristics and prognostic implication. Eur Heart J Cardiovasc Imaging. 2012;13:416–422.
   PubMed Web of Science ®Google Scholar
• Gertz MA, Grogan M, Kyle RA, et al. Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy. Am J Cardiol. 1997;80:93–95.
   PubMed Web of Science ®Google Scholar
• Bellavia D, Pellikka PA, Abraham TP, et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol. 2008;101:1039–1045.
   PubMed Web of Science ®Google Scholar
• Suresh R, Grogan M, Maleszewski JJ, et al. Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr. 2014;27:440–447.
   PubMed Web of Science ®Google Scholar
• Sedaghat-Hamedani F, Kayvanpour E, Frankenstein L, et al. Biomarker changes after strenuous exercise can mimic pulmonary embolism and cardiac injury - a metaanalysis of 45 studies. Clin Chem. 2015;61:1246–1255.
   PubMed Web of Science ®Google Scholar
• Palladini G, Campana C, Klersy C, et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation. 2003;107:2440–2445.
   PubMed Web of Science ®Google Scholar
• Di Bella G, Minutoli F, Piaggi P, et al. Usefulness of combining electrocardiographic and echocardiographic findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation. Am J Cardiol. 2015;116:1122–1127.
   PubMed Web of Science ®Google Scholar
• Aurich M, André F, Keller M, et al. Assessment of left ventricular volumes with echocardiography and cardiac magnetic resonance imaging: real-life evaluation of standard versus new semiautomatic methods. J Am Soc Echocardiogr. 2014;27:1017–1024.
   PubMed Web of Science ®Google Scholar
• Malm S, Frigstad S, Sagberg E, et al. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol. 2004;44:1030–1035.
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Von Bardeleben S, Kasprzak JD, et al. Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography: a multicenter comparison of methods. J Am Coll Cardiol. 2006;47:121–128.
   PubMed Web of Science ®Google Scholar
• Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53:802–810.
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Von Bardeleben S, Barletta G, et al. Comparison of two- and three-dimensional unenhanced and contrast-enhanced echocardiographies versus cineventriculography versus cardiac magnetic resonance for determination of left ventricular function. Am J Cardiol. 2014;113:395–401.
   PubMed Web of Science ®Google Scholar
• Malm S, Frigstad S, Stoylen A, et al. Effects of ultrasound contrast during tissue velocity imaging on regional left ventricular velocity, strain, and strain rate measurements. J Am Soc Echocardiogr. 2006;19:40–47.
   PubMed Web of Science ®Google Scholar
• Cavalcante JL, Collier P, Plana JC, et al. Two-dimensional longitudinal strain assessment in the presence of myocardial contrast agents is only feasible with speckle-tracking after microbubble destruction. J Am Soc Echocardiogr. 2012;25:1309–1318.
   PubMed Web of Science ®Google Scholar
• Dandel M, Lehmkuhl H, Knosalla C, et al. Strain and strain rate imaging by echocardiography - basic concepts and clinical applicability. Curr Cardiol Rev. 2009;5:133–148.
   PubMedGoogle Scholar
• Aurich M, Keller M, Greiner S, et al. Left ventricular mechanics assessed by two-dimensional echocardiography and cardiac magnetic resonance imaging: comparison of high-resolution speckle tracking and feature tracking. Eur Heart J Cardiovasc Imaging. 2016 Mar 24. pii: jew042. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar